intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1
Thymosin Beta 4 has not been evaluated for tendon or muscle regeneration, but the peptide may accelerate musculoskeletal healing following injury and exercise
Trouble Shooting & FAQ What if I bent the needle
Over time, the soda may become more tangy as fermentation slowly continues
Your body must convert it into one of the active forms before it can use it
RecoveryFocused Consult $100 We review your injury history, current pain points, activity level, and goals , and decide if BPC157/TB500 makes sense for you